This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sven Nylander: Innovator in Recombinant Protein Treatments
Introduction
Sven Nylander is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments. His work focuses on the administration of recombinant proteins in conjunction with specific inhibitors.
Latest Patents
Sven Nylander holds a patent for a groundbreaking invention titled "Combination Treatment by Administering a Recombinant Apyrase Protein in Conjunction with a P2Y12 Inhibitor." This patent represents a significant advancement in therapeutic strategies, potentially improving patient outcomes in various medical conditions.
Career Highlights
Sven is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development, where he applies his expertise to create effective treatment solutions. His innovative approach has garnered attention within the scientific community.
Collaborations
Sven has collaborated with esteemed colleagues, including Leif Carlsson and Ola Fjellstrom. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Sven Nylander's contributions to biotechnology and his innovative patent highlight his commitment to advancing medical treatments. His work at AstraZeneca AB and collaborations with fellow researchers underscore the importance of teamwork in scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile